Currently in phase III trials, the 64Cu-SAR-bisPSMA PET agent reportedly offers a longer half-life and higher tumor uptake than other radiopharmaceuticals for prostate cancer imaging.

For patients who had post-op recurrence after a Whipple procedure for pancreatic ductal adenocarcinoma (PDAC), between 80 to 86 percent of follow-up CT exams revealed new or increased soft tissue.

Combining four CAD modules for valvular pathologies with a variety of automated measurements, the AI-enabled AISAP Cardio ultrasound system reportedly facilitates up to a 90 percent accuracy rate in detecting common cardiac conditions.

The AI-powered qCT LN Quant software reportedly generates 2D and 3D reconstructions and facilitates assessment of morphologic data across multiple thoracic studies.

Key features of the HealthCCSng V2.0 software include numerical coronary artery calcium (CAC) scoring, a new zero CAC category and user customization of upper and lower limits for CAC scoring categories.

A new MRI contrast agent may provide a viable non-invasive alternative for the detection of interstitial cystitis, according to preliminary research presented at the 5th International Consultation on Interstitial Cystitis Japan (ICICJ) in Kyoto, Japan.

Adding two key findings from contrast-enhanced ultrasound to a predictive model of mammography, conventional ultrasound and clinicopathological findings led to a 86.1 percent AUROC for predicting the upgrading of ductal carcinoma in situ to invasive breast cancer, according to new research.

Providing an 85.7 percent sensitivity rate for detecting cerebral aneurysms on computed tomography angiography (CTA), the deep learning model also offered a similar AUC (93 percent) in comparison to radiology reports (91 percent).

New research suggests the use of an AI software may help rule out pathology on over 50 percent of unremarkable chest X-rays with a 98 percent sensitivity threshold.

Detecting cerebral microbleed (CMB) in one of six healthy adults in a new study, researchers also found that CMB was the only MRI marker of small vessel disease (SVD) to be significantly associated with traumatic brain injury (TBI).

From questionable quality with images on CDs to issues with rad group portals, challenges continue to persist with access to imaging.

For patients with stable chest pain, CT angiography demonstrated a nearly 40 percent higher sensitivity rate than exercise electrocardiography and over an 18 percent higher sensitivity rate than SPECT for detecting obstructive coronary artery disease (CAD).

Catch up on the top radiology content of the past week.

Acute clinical events with stable MRI (ACES) in patients with multiple sclerosis (MS) are reportedly associated with significantly higher rates of confirmed disability accrual, relapse-associated worsening, and transition to secondary progressive MS.

While cone-beam computed tomography (CBCT) demonstrated high pooled sensitivity and specificity rates for intraparenchymal hemorrhage in the systematic review, researchers noted higher false-negative rates for subarachnoid and intraventricular hemorrhages.

Based on surveys of neuro-oncologists taken before and after the use of MRI perfusion imaging and spectroscopy in patients with high-grade gliomas, researchers found the advanced imaging would have led to a greater than fivefold change in patient management in comparison to previous research.

Offering a variety of AI features for streamlined workflow and enhanced visualization, the Acuson Origin ultrasound system also features the newly FDA-cleared AcuNav Lumos 4D ICE (intracardiac echocardiography) catheter.

Utilizing low-dose computed tomography (CT) scans for a cohort of over 10,000 non-smokers, researchers found that over 11 percent of study participants had clinically relevant lung nodules.

Review the case and test your knowledge to make the correct diagnosis.

In a recent interview, Soroush Rais-Bahrami, M.D., discussed key findings from a post-hoc subgroup analysis of the SPOTLIGHT trial that examined the use of the PET imaging agent 18F-flotufolastat (Posluma) in African American men.